An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes
Vincent J Vezza1, Adrian Butterworth1, Perrine Lasserre1
1Biomedical Engineering, University of Strathclyde, Glasgow, G1 1XP, UK. vincent.vezza@strath.ac.uk.
Chemical Communications (Cambridge, England)
|March 17, 2021
Summary
Accurate diagnostic tests are crucial for controlling SARS-CoV-2. This research shows promising early results for a new test using the ACE2 enzyme for sensitive, specific, and rapid detection.
Area of Science:
- Biochemistry
- Medical Diagnostics
- Virology
Background:
- Accurate and rapid diagnostic tests are essential for mitigating the impact of SARS-CoV-2.
- The development of effective diagnostic tools is crucial for public health strategies.
Purpose of the Study:
- To present early findings on a novel SARS-CoV-2 diagnostic test.
- To evaluate the potential of the ACE2 enzyme as a recognition element for SARS-CoV-2 detection.
Main Methods:
- Utilizing the Angiotensin-Converting Enzyme 2 (ACE2) enzyme as the core recognition element.
- Developing a diagnostic approach for SARS-CoV-2 detection based on ACE2 interaction.
Main Results:
- Demonstrated early, promising measurements of SARS-CoV-2.
- The ACE2-based method shows potential for clinically relevant detection.
Conclusions:
- The developed test offers a scalable pathway for sensitive, specific, rapid, and low-cost mass testing for SARS-CoV-2.
- This approach holds promise for improving global diagnostic capabilities.
